Evaristo Akerele, MD, MPH, DFAPA, Department of Psychiatry, Columbia University Medical Center, New York, New York; Interfaith Medical Center, Brooklyn, New York

Sudie E. Back, PhD, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, and Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina

Nicolas Badre, MD, San Diego Central Jail, San Diego, California

D. Andrew Baron, MS, Pasadena, California

David A. Baron, DO, Department of Psychiatry, University of Southern California, Los Angeles, California

Kelly S. Barth, DO, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina

Judith S. Beck, PhD, Beck Institute for Cognitive Behavior Therapy, and Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

Kathleen T. Brady, MD, PhD, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, and Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina

Christina Brezing, MD, Department of Psychiatry, Columbia University Medical Center, and Division on Substance Abuse, New York State Psychiatric Institute, New York, New York

Oscar G. Bukstein, MD, Department of Psychiatry, Boston Children’s Hospital, Boston, Massachusetts

Kenneth M. Carpenter, PhD, Department of Psychiatry, Columbia University Medical Center, and Division on Substance Abuse, New York State Psychiatric Institute, New York, New York

Kathleen M. Carroll, PhD, Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut

Joseph DiFranza, MD, Department of Community Medicine and Family Health, University of Massachusetts Medical School, Worcester, Massachusetts

Lance M. Dodes, MD (retired), Department of Psychiatry, Harvard Medical School, Boston, Massachusetts

Caroline M. DuPont, MD, The Institute for Behavior and Health, Inc., Rockville, Maryland

Robert L. DuPont, MD, The Institute for Behavior and Health, Inc., Rockville, Maryland

John Franklin, MD, MSc, Department of Psychiatry and Behavioral Sciences, Northwestern University, Chicago, Illinois

Marc Galanter, MD, Division of Alcoholism and Drug Abuse, Department of Psychiatry, NYU School of Medicine, NYU Langone Medical Center, New York, New York

Robert Gorney, MD, Richard J. Donovan Correctional Facility, California Department of Corrections and Rehabilitation, San Diego, California

Jon E. Grant, MD, Department of Psychiatry and Behavioral Neurosciences, University of Chicago, Chicago, Illinois

William M. Greene, MD, Division of Addiction Medicine, Department of Psychiatry, University of Florida College of Medicine, Gainesville, Florida

Shelly F. Greenfield, MD, MPH, Department of Psychiatry, Harvard Medical School, Boston, Massachusetts; Division of Alcohol and Drug Abuse and Division of Women’s Mental Health, McLean Hospital, Belmont, Massachusetts

Colin N. Haile, MD, PhD, Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, and Michael E. DeBakey VA Medical Center, Houston, Texas

Deborah L. Haller, PhD, ABPP, Department of Public Health Sciences, University of Miami Miller Medical School, Miami, Florida

Amy Harrington, MD, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts

Deborah Hasin, PhD, Department of Psychiatry, Columbia University Medical Center, New York, New York

Abigail J. Herron, DO, The Institute for Family Health and Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York

Dorian Hunter, PhD, private practice, Seattle, Washington

Dilip V. Jeste, MD, Department of Psychiatry and the Stein Institute for Research on Aging, UC San Diego Health Sciences, San Diego, California

Laura M. Juliano, PhD, Department of Psychology, American University, Washington, DC

David Kalman, PhD, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts

Yifrah Kaminer, MD, Department of Psychiatry, University of Connecticut School of Medicine, Farmington, Connecticut

Edward Kaufman, MD, Northbound Treatment Services, Newport Beach, California

Cheryl Ann Kennedy MD, DFAPA, Department of Psychiatry and Department of Preventive Medicine and Community Health, Rutgers New Jersey Medical School, Newark, New Jersey

Edward J. Khantzian, MD, Department of Psychiatry, Harvard Medical School, Boston, Massachusetts

Bari Kilcoyne, MPH, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, New York

Brian D. Kiluk, PhD, Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut

Steve Koh, MD, MPH, MBA, Department of Psychiatry, UC San Diego Health Sciences, San Diego, California

Thomas R. Kosten, MD, Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas

Frances R. Levin, PhD, Division on Substance Abuse, New York State Psychiatric Institute, New York, New York

Petros Levounis, MD, Department of Psychiatry, Rutgers New Jersey Medical School, Newark, New Jersey

Bruce S. Liese, PhD, Department of Psychology, University of Kansas, Lawrence, Kansas

Marsha M. Linehan, PhD, Behavioral Research and Therapy Clinics, University of Washington, Seattle, Washington

Walter Ling, MD, UCLA Integrated Substance Abuse Programs, Los Angeles, California

Thomas R. Lynch, PhD FBPsS, School of Psychology, University of Southampton, Southampton, United Kingdom

Avram H. Mack, MD, Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania

Elinore F. McCance-Katz, MD, State of Rhode Island Department of Behavioral Healthcare, Developmental Disabilities and Hospitals, Providence, Rhode Island

Jenna L. McCauley, PhD, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina

Larissa J. Mooney, MD, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, and UCLA Integrated Substance Abuse Programs, Los Angeles, California

Alicia R. Murray, DO, private practice, White Plains, New York

Ed Nace, MD, Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas

Niru Nahar, MD, Department of Psychiatry, Harlem Hospital, Columbia University Medical Center, New York, New York

Lisa M. Najavits, PhD, Department of Psychiatry, Boston University School of Medicine, and Veterans Affairs Healthcare System, Boston, Massachusetts

Edward V. Nunes, MD, Department of Psychiatry, Columbia University Medical Center, and Division on Substance Abuse, New York State Psychiatric Institute, New York, New York

Lori Pbert, PhD, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts

Marc N. Potenza, MD, PhD, Departments of Psychiatry and Neuroscience and Child Study Center, Yale School of Medicine, New Haven, Connecticut

Greta Bielaczyc Raglan, MA, Department of Psychology, American University, Washington DC

Richard Rawson, PhD, UCLA Integrated Substance Abuse Programs, Los Angeles, California

M. Zachary Rosenthal, PhD, Department of Psychiatry and Behavioral Sciences and Department of Psychology and Neuroscience, Duke University, Durham, North Carolina

Richard N. Rosenthal, MD, Center for Addictive Disorders, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York

Stephen Ross, MD, Department of Psychiatry, NYU School of Medicine, NYU Langone Medical Center, New York, New York

Steven J. Schleifer, MD, Department of Psychiatry, Rutgers New Jersey Medical School, Newark, New Jersey

Sidney H. Schnoll, MD, PhD, Pinney Associates, Inc., Bethesda, Maryland

Liana R. N. Schreiber, MPH, Department of Psychiatry, University of Minnesota, Minneapolis, Minnesota

Benjamin C. Silverman, MD, Department of Psychiatry, Harvard Medical School, and Partners Human Research Committee, Partners HealthCare, Boston, Massachusetts

Jennifer L. Smith, PhD, Department of Psychiatry, Columbia University Medical Center, and Division on Substance Abuse, New York State Psychiatric Institute, New York, New York

Dawn E. Sugarman, PhD, Department of Psychiatry, Harvard Medical School, Boston, Massachusetts; Division of Alcohol and Drug Abuse and Division of Women’s Mental Health, McLean Hospital, Belmont, Massachusetts

R. Morgan Wain, PhD, Division on Substance Abuse, New York State Psychiatric Institute, New York, New York

Roger D. Weiss, MD, Department of Psychiatry, Harvard Medical School, Boston, Massachusetts; Division of Alcohol and Drug Abuse, McLean Hospital,Belmont, Massachusetts

Joseph Westermeyer, MD, PhD, Department of Psychiatry, University of Minnesota, and Minneapolis VA Medical Center, Minneapolis, Minnesota

Laurence Westreich, MD, Department of Psychiatry, NYU School of Medicine, NYU Langone Medical Center, New York, New York

Douglas Ziedonis, MD, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts